Evidence map›Paper›PMID 21034245›Full record

ArticleJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics2010

Immunization with pneumolysin protects against both retinal and global damage caused by Streptococcus pneumoniae endophthalmitis.

Melissa E Sanders, Erin W Norcross, Quincy C Moore, Jonathan Fratkin, Hilary Thompson, Mary E Marquart

Open access · greenAbstract read
In one paragraph

Article in Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Diverse Mechanisms of Protective Anti-Pneumococcal Antibodies.Frontiers in cellular and infection microbiology · 2022
    Review
  4. Pneumolysin: Pathogenesis and Therapeutic Target.Frontiers in microbiology · 2020
    Review
  5. Review
  6. Targets of immunomodulation in bacterial endophthalmitis.Progress in retinal and eye research · 2019
    Review
  7. Article
  8. Article
  9. The Role of Pneumococcal Virulence Factors in Ocular Infectious Diseases.Interdisciplinary perspectives on infectious diseases · 2018
    Review
  10. Modeling intraocular bacterial infections.Progress in retinal and eye research · 2016
    Review
  11. Article
  12. Role of pore-forming toxins in bacterial infectious diseases.Microbiology and molecular biology reviews : MMBR · 2013
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Melissa E SandersDepartment of Microbiology, University of Mississippi Medical Center, Jackson, MS 39216, USA.
Erin W Norcross
Quincy C Moore
Jonathan Fratkin
Hilary Thompson
Mary E Marquart
University of Mississippi Medical Center · USJackson Memorial Hospital · USLouisiana State University Health Sciences Center New Orleans · US

Funding

Streptococcus pneumoniae ocular pathogenesis and therapyR01EY016195 · NEI · UNIVERSITY OF MISSISSIPPI MED CTR · PI MARQUART, MARY E · 2007 to 2011
$1.5M
NEI NIH HHS R01 EY016195
6 · The paper itself

Abstract

purposeTo determine whether immunization with pneumolysin (PLY) protects against pneumococcal endophthalmitis.

methodsNew Zealand white rabbits were immunized with a mutant form of PLY that retains only 1% of its cytolytic activity until serum IgG titers were ≥51,200. For a negative control, rabbits were immunized with phosphate-buffered saline (mock). Each vitreous was injected with 10(2) colony-forming units of a clinical endophthalmitis isolate of Streptococcus pneumoniae. Severity of endophthalmitis was graded by slit lamp examination at 24 and 48 h postinfection (PI). Serial dilutions of vitreous were plated for bacterial colony-forming units quantitation, eyes were extracted for histology, and a whole blood survival assay was performed.

resultsImmunized rabbits had a significantly lower mean slit lamp examination score at 24 and 48 h PI when compared to mock immunized rabbits (P ≤ 0.002). There was not a significant difference in bacterial load in the vitreous at 24 or 48 h PI. Histological sections showed that retinas of mock immunized rabbits appeared to be destroyed, whereas those of PLY immunized rabbits remained largely intact. Damage spread to the aqueous humor, stroma, and conjunctiva of mock immunized rabbits by 48 h PI. Minimal damage was observed in the vitreous of PLY immunized rabbits and did not spread to other parts of the eye. Whole blood from immunized rabbits inhibited the growth of bacteria better than whole blood from mock immunized rabbits.

conclusionImmunization with PLY helps protect the eye from damage caused by pneumococcal endophthalmitis.

Indexed as

AnimalsBacterial ProteinsEndophthalmitisEyeImmunoglobulin GPneumococcal InfectionsRabbitsRetinaSeverity of Illness IndexStreptococcus pneumoniaeStreptolysinsTime FactorsVaccinationBacterial ProteinsImmunoglobulin GplY protein, Streptococcus pneumoniaeStreptolysins

Identifiers

PMID21034245
PMCPMC2990286
OpenAlexW2028158421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.